Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
08/14/2003WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066880A2 Method for accessing microbial diversity
08/14/2003WO2003066874A1 Degradation of hydrophobic ester pesticides and toxins
08/14/2003WO2003066871A2 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds
08/14/2003WO2003066868A1 Retroviral vectors pseudotyped with influenza virus hemagglutinin for gene delivery
08/14/2003WO2003066856A1 METHOD OF DIFFERENTIATING/INDUCING BONE MARROW INTERSTITIAL CELLS INTO NERVE CELLS AND SKELETON MUSCLE CELLS BY TRANSFERRING Notch GENE
08/14/2003WO2003066855A1 Swine rag-1 gene and utilization thereof
08/14/2003WO2003066847A2 Phytase variants
08/14/2003WO2003066843A2 Method for the production of a nerve transplant
08/14/2003WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
08/14/2003WO2003066839A1 Lineage committed stem cells selected for telomerase promoter activity
08/14/2003WO2003066832A2 Generation of new insulin cells from progenitor cells present in adult pancreatic islets
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066810A2 Recombinant bovine immunodeficiency virus based gene transfer system
08/14/2003WO2003066805A2 Antisense modulation of complement component c3 expression
08/14/2003WO2003066804A2 Thermus scotoductus nucleic acid polymerases
08/14/2003WO2003066675A1 Gene conferring resistance to phytophthora infestans (late-blight) in solanacea
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066663A2 Peptides for recognition and targeting of glial cell tumors
08/14/2003WO2003066661A2 Human dr4 antibodies and uses thereof
08/14/2003WO2003066110A1 Pathogen reduction solution for platelets containing an endogenous photosensitizer and a glycolysis inhibitor.
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy
08/14/2003WO2003065986A2 FcϵRI-BEARING HUMAN MAST CELL LINES
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065977A2 Modified antigen-presenting cells
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003048309A3 Thermus thermophilus nucleic acid polymerases
08/14/2003WO2003035845A3 Salvador tumor suppressor gene
08/14/2003WO2003034034A3 Automated system and method for processing multiple liquid-based specimens
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003028637A3 Antisense modulation of sphingosine-1-phosphate lyase expression
08/14/2003WO2003026395A3 Mo54 gene disruptions, compositions and methods related thereto
08/14/2003WO2003023642A3 Arrangement with artificial neurons for describing the transmission behavior of a nerve cell to be excited and method for determining the transmission behavior of a nerve cell to be excited using artificial neurons
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003018764A3 Novel human proteases and polynucleotides encoding the same
08/14/2003WO2003017935A3 Human antibodies specific for interleukin 15 (il-15)
08/14/2003WO2003012060A3 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
08/14/2003WO2003006613A3 Methods for ex vivo propagation of somatic stem cells
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002097102A3 Modification of plant genomes by inducible site-specific recombination of trans genes
08/14/2003WO2002059154A9 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002038601A3 Foggy
08/14/2003WO2002031130A9 Manipulation of soluble carbohydrates
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020733A3 Genes involved in isoprenoid compound production
08/14/2003WO2002018609A9 Methods for stable transduction of cells with viral vectors
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030154509 Control of gene expression in plants
08/14/2003US20030154506 Process of generating stem cells equivalent to human embryonic stem cells
08/14/2003US20030154505 Transgenic non-human mammal with an oncogenic mutant of the c-Raf-1 gene
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153082 An isolated population of human hematopoietic cells that proliferates in culture, obtained by differentiating primate pluripotent stem (pPS) cells, and atleast 1% cells are CD45 + and population forms colonies
08/14/2003US20030153080 Methods for improving conifer embryogenesis
08/14/2003US20030153079 Agglomerating a nutritive medium powder, medium supplement powder, nutritive medium subgroup powder, or buffer powder with a solvent containing atleast one lipid dissolved for incorporatin in the medium powder
08/14/2003US20030153078 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material
08/14/2003US20030153077 Method to increase the rate of cell growth
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153074 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation
08/14/2003US20030153073 Expansion of T cells in vitro and expanded T cell populations
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153045 Methods and compositions for protein expression and purification
08/14/2003US20030153044 Tissues or organs for use in xenotransplantation
08/14/2003US20030153039 Using hybridomas cells; gene expression; monoclonal antibodies
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153032 Antitumor agents; exposur eof cell antigen to proteas
08/14/2003US20030153025 Cell-based drug screens for regulators of gene expression
08/14/2003US20030153015 Compositions and methods for the treatment of immune related diseases
08/14/2003US20030153000 Genetic engineering; culture product; recovering
1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 1827